CVS Health在CMS星级评定中的强劲表现对公司来说是一个积极的发展。4.5星计划会员比例的大幅增长表明CVS提供的服务质量和吸引力有所提升。这可能会带来更高的客户满意度和忠诚度，这对公司的长期成功至关重要。 根据TD Cowen的分析，最新的星级评定证实了他们早前的升级分析，并增强了他们对CVS Health Medicare ...

CVS Health公司发言人周五表示，该公司正在关闭其核心输液服务业务，并计划在未来几个月内关闭或出售29家相关地区药店。公司通讯部高级经理Shelly Bandit称，公司于10月8日停止接收寻求 抗生素 ...

CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in ...

Barclays upgraded CVS Health (NYSE:CVS) to Overweight from Equal Weight on Thursday, citing a compelling path to margin ...

巴克莱将医疗保健集团CVS Health的评级从“中性”上调至“增持”，目标价从63美元上调至82美元。

CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...

CVS Health's Coram discontinues infusion services for antibiotics, inotropic meds, and more, plans to close or sell 29 regional pharmacies.

The cuts are part of a large-scale, $2 billion savings plan unveiled by executives in August. The Woonsocket, Rhode ...

Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...

Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...

TD Cowen上调了对CVS Health (NYSE: CVS)的评级，将该股票从持有上调至买入。该公司还将CVS股票的目标价从59.00美元上调至85.00美元，显示出投资者可能获得可观的上涨空间。 这次股票前景的修正是在CVS发布2025年Medicare Advantage (MA)计划福利后做出的。据分析师称，该公司大幅削减了非处方药(OTC)福利和牙科津贴。此外，2025年评级为4星 ...

焦点股：●CVS Health收涨2.4%，报导指出，对冲基金Glenview Capital Management将与该医疗保健公司高层会面，并提出改善营运的方法。●EchoStar周一下跌11.48%，盘中一度暴跌20%。美国卫星电视业者DirecTV宣布将收购 ...